MedStar Health Research Institute/MedStar Washington Hospital Center

Washington D.C., District of Columbia 20010

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Coronavirus, SARS-CoV-2, Sickle Cell Disease

Studies at this site

• A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD) — Completed
• Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults — Completed